2025
|
Invention
|
Switchable building component. A building component comprises: a first chamber locatable on or ad... |
2024
|
Invention
|
An antimicrobial material. A polymeric material comprising solid peroxide embedded therein. The p... |
|
Invention
|
A phenothiazine-related compound conjugated to a peptide. Staphylococcus aureus, Pseudomonas aeru... |
|
Invention
|
Polymersomes with methacrylate. The present invention relates to drug delivery, more specifically... |
|
Invention
|
A fusion peptide for activation of the apj and / or glp-1 receptors. A Fusion Peptide for Activat... |
2023
|
Invention
|
Compositions for use in the treatment of diabetes or obesity. The present invention relates to co... |
|
Invention
|
A sensitizer- peptide conjugate.
The present invention relates to a sensitizer-peptide conjugate... |
|
Invention
|
Visual field sensitivity testing. The present invention is concerned with a method and an instrum... |
|
G/S
|
Scientific, research, audiovisual, teaching apparatus and instruments; apparatus and instruments ... |
2022
|
Invention
|
Compositions for use in the treatment of neurological disease.
The present invention relates to ... |
|
Invention
|
A cell based test to monitor dmard drug response.
This invention relates to predicting a subject... |
|
Invention
|
A cell based test to monitor dmard drug response. This invention relates to predicting a subject'... |
|
Invention
|
Microbubble-chemotherapeutic agent complex for sonodynamic therapy.
The invention relates to met... |
|
Invention
|
An isolated polypeptide.
The present invention relates to an isolated polypeptide that finds uti... |
|
Invention
|
An isolated polypeptide. The present invention relates to an isolated polypeptide that finds util... |
2021
|
Invention
|
Neurodegenerative treatment. The invention relates to an isolated polysaccharide and a compositio... |
|
Invention
|
A method of predicting response to treatment with a disease-modifying anti-rheumatic drug, and/or... |
|
Invention
|
A method of diagnosing depression in a subject.
The present invention relates to a method of dia... |
|
Invention
|
A method of diagnosing depression in a subject. The present invention relates to a method of diag... |
|
Invention
|
A genetic test to predict anti-tnf drug response.
This invention relates to predicting a subject... |
|
Invention
|
A genetic test to predict anti-tnf drug response. This invention relates to predicting a subject'... |
|
Invention
|
Image classification using retinal ganglion cell modelling. A method of processing a digital imag... |
|
Invention
|
Improvements in and relating to image classification using retinal ganglion cell modelling. A met... |
|
Invention
|
Polypeptides and analogues thereof for use in the treatment of diabetes and bone disorders. The p... |
2020
|
Invention
|
A method of isolating exosomes. The present invention relates to a method of isolating exosomes. ... |
|
Invention
|
Control of tumour growth and gut bleeding by biosurfactants. The present disclosure relates to ac... |
|
Invention
|
Pharmaceutical delivery device and method of manufacture.
A pharmaceutical delivery device, comp... |
|
Invention
|
Pharmaceutical delivery device and method of manufacture. A pharmaceutical delivery device, compr... |
|
Invention
|
Compositions for use in the treatment of diabetes. This invention relates to compositions for use... |
|
Invention
|
Lateral flow immunoassay device.
A lateral flow immunoassay device includes a porous test strip,... |
|
Invention
|
Lateral flow immunoassay device. A lateral flow immunoassay device comprising a porous test strip... |
|
Invention
|
Method and system for generating optical spectra. A method of generating an optical spectrum for ... |
|
Invention
|
A method for predicting a psychiatric disorder. The present invention relates to a method for pre... |
2019
|
Invention
|
Bispecific antibody targeting il-1r1 and nlpr3. The present disclosure concerns modulators of the... |
|
Invention
|
A method of diagnosing or prognosing a neurological disorder.
The present invention relates to a... |
|
Invention
|
A method of diagnosing or prognosing a neurological disorder. The present invention relates to a ... |
|
Invention
|
Piscine-derived pyy peptides for use in treating a metabolic disorder.
The present invention rel... |
|
Invention
|
Piscine-derived pyy peptides for use in treating a metabolic disorder disorder. The present inven... |
2018
|
Invention
|
Sensitizer-peptide conjugate. The present invention relates to a sensitizer-peptide conjugate for... |
|
Invention
|
A sensitizer - peptide conjugate. The present invention relates to a sensitizer-peptide conjugate... |
|
Invention
|
Sonodynamic therapy. The invention relates to microbubble complexes for use in methods of sonodyn... |
|
Invention
|
Calcium peroxides nanoparticles as adjuvant therapy. 2 nanoparticles, together with at least one ... |
|
Invention
|
Pharmaceutical composition for use in the treatment of a neurodegenerative disease.
The present ... |
|
Invention
|
Method and apparatus for producing nanoscale materials. A method of producing nanoscale materials... |
2016
|
Invention
|
Liquid sample collection apparatus.
This invention relates to a liquid sample collection apparat... |
|
G/S
|
Information technology and audiovisual equipment; Measuring, detecting and monitoring instruments... |